Previously, we discovered that C4d, but not C3 or C4, was an accurate marker to distinguish between remission and flare, as well as to predict future LN flares in relapsing patients in a cross-sectional SLE cohort (8). This evidence concerns the gene C3 and systemic lupus erythematosus.